Direct Pharmacy

Direct Pharmacy
HomeAlpha IndexCategories

Bookmark and Share

Products : A

Products : B

Products : C

Products : D

Products : E

Products : F

Products : G

Products : H

Products : I

Products : J

Products : K

Products : L

Products : M

Products : N

Products : O

Products : P

Products : Q

Products : R

Products : S

Products : T

Products : U

Products : V

Products : W

Products : X

Products : Y

Products : Z

Products : 0-9

Home

Product Index

Category List

Catapres TTS 3 Generic Clonidine

Home » Prescription Drugs 4 » Catapres TTS 3 Generic Clonidine

Indications:CATAPRES-TTS is indicated for the treatment of mild to moderate hypertension. It can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.Dosage and Administration:CATAPRES-TTS dosage should be titrated according to individual patient's therapeutic requirements. Commence with one CATAPRES-TTS-1 applied weekly to a freshly cleaned hairless area of the upper outer arm or chest. A new site should be used each week when applying new patches. If after two to four weeks the desired reduction in blood pressure is not achieved increase the weekly dosage by changing to CATAPRES-TTS-2. If this dosage is still not satisfactory after 2-4 weeks therapy then increase the weekly dosage by changing to CATAPRES-TTS-3.Most patients with mild to moderate hypertension will be controlled on one CATAPRES-TTS-3 or less. In more resistant cases where blood pressure is not satisfactorily controlled on one CATAPRES-TTS-3 it is recommended that a diuretic and/or other antihypertensive agents be added to enhance the hypotensive effect. In this way the dose of each individual drug may be reduced and side effects minimised. Higher doses of up to two CATAPRES-TTS-3 a week have been utilised.When substituting CATAPRES-TTS in patients on prior oral antihypertensive therapy including oral CATAPRES physicians should be aware that the antihypertensive effect of CATAPRES-TTS might not commence until 2-3 days after initial application. Therefore gradual reduction of prior drug dosage over 5-6 days is advised.Instructions on correct application of CATAPRES-TTS are provided on a separate patient leaflet.

Buy Catapres TTS 3 Generic Clonidine and other Prescription Drugs 4 products online at Medstore.

5464
Buy Online at Medstore - Click Here!

About Catapres TTS 3 Generic Clonidine:

Product Type: Prescription Drugs 4

Catapres TTS-3 ( Generic Clonidine )

Catapres TTS-3 (Generic Clonidine)

Generic Clonidine

7.5mg/10.5cm 4 Pads Generic Clonidine Catapres TTS-3

View more Prescription Drugs 4

Previous Product  Next Product

Direct Pharmacy: About Medstore Discount Drugs Pharmacy: Frequently Asked Questions Where are you located? We have shipping facilities in the South Pacific, Europe and the Asia. The shipping address depends on the product you have ordered and from which manufacturer or wholesaler it is being supplied from.
 
News: Micronutrient powder helps prevent malnutrition in children up to two years old, study review shows In a systematic review published by the Cochrane Collaboration last week, researchers found that the micronutrient powder used in recent years to combat malnutrition, anemia and iron deficiency in children was very helpful in preventing malnutrition in children six to 24 months old, VOA News reports. WHO epidemiologist Luz Maria De Regil "and other researchers combined the results of eight previous studies involving thousands of children," VOA writes, adding, "The studies were done on three continents, in countries as varied as Haiti, Cambodia and Ghana." "Specifically, the supplement powder reduced anemia by about one-third and iron deficiency by half compared to no supplement or a placebo," VOA notes. "The micronutrient powder seems to be about equally effective as iron supplements, but the authors say that conclusion should be treated 'cautiously,' because of limited data," the news service adds (Chimes, 9/9). This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.
 
ZAART H Hyzaar 
Zanaflex (Tizanidine) 
Zantac Generic Ranitidine 
Zantac (Ranitidine) 
Zarontin Generic Ethosuximide 
Zarontin Syrup Generic Ethosuximide 
Zebeta (Bisoprolol) 
Zeffix Generic Imaivudine 
Zelnorm (Tegaserod) 
Zerit (Stavudine) 
Zero Nicotine 
Zestoretic (Lisinopril + Hydrochlorothiazide) 
Zestril (Lisinopril) 
Zestril Prinivil 
Zetia (Ezetimibe) 
ZIDOVIR 300 AZT 
ZIDOVIR AZT 
Ziprax Suprax 
Zipsydon Geodon 
Zithromax Generic Azithromycin 
Zithromax (Azithromycin) 
Zitrotek Zithromax 
ZOBID D Voltaren 
Zocon Diflucan 
Zocor 
Zocor Forte Lipex 
Zocor (Simcard) 
ZOFLUT Generic Fluticasone 
Zofran Generic Ondansetron 
Zofran (Ondansetron) 
Zoladex Generic Goserelin 
Zoloft Lustral 
Zomig Generic Zolmitriptan 
ZONISEP Zonegran 
Zoton Prevacid